Telomere replication: Poised but puzzling

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 1, 2011, Pages 3-13

  Sampathi, Shilpa ^a,b   Chai, Weihang ^a,b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

C strand fill in; Cancer; G quadruplex; Shelterin; Telomerase; Telomere replication

Indexed keywords

TELOMERASE;

ANIMAL; ARTICLE; DNA REPLICATION; GENETICS; HUMAN; METABOLISM; TELOMERE;

ANIMALS; DNA REPLICATION; HUMANS; TELOMERASE; TELOMERE;

EID: 78751694443     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01220.x     Document Type: Article

References (143)

1. Makarov VL, Hirose Y, Langmore JP. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell. 1997; 88: 657-66.
2. Wright WE, Tesmer VM, Huffman KE, et al Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev. 1997; 11: 2801-9.
3. Chai W, Du Q, Shay JW, et al Human telomeres have different overhang sizes at leading versus lagging strands. Mol Cell. 2006; 21: 427-35.
4. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2005; 19: 2100-10.
5. Palm W, de Lange T. How shelterin protects mammalian telomeres. Annu Rev Genet. 2008; 42: 301-34.
6. de Lange T. How telomeres solve the end-protection problem. Science. 2009; 326: 948-52.
7. Bianchi A, Shore D. How telomerase reaches its end: mechanism of telomerase regulation by the telomeric complex. Mol Cell. 2008; 31: 153-65.
8. Wright WE, Piatyszek MA, Rainey WE, et al Telomerase activity in human germline and embryonic tissues and cells. Dev Genet. 1996; 18: 173-9.
9. Smogorzewska A, van Steensel B, Bianchi A, et al Control of human telomere length by TRF1 and TRF2. Mol Cell Biol. 2000; 20: 1659-68.
10. Houghtaling BR, Cuttonaro L, Chang W, et al A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2. Curr Biol. 2004; 14: 1621-31.
11. Li B, de Lange T. Rap1 affects the length and heterogeneity of human telomeres. Mol Biol Cell. 2003; 14: 5060-8.
12. Loayza D, De Lange T. POT1 as a terminal transducer of TRF1 telomere length control. Nature. 2003; 424: 1013-8.
13. Collins K. The biogenesis and regulation of telomerase holoenzymes. Nat Rev Mol Cell Biol. 2006; 7: 484-94.
14. Goldblatt EM, Gentry ER, Fox MJ, et al The telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits growth, and augments the effects of paclitaxel. Mol Cancer Ther. 2009; 8: 2027-35.
15. Goldblatt EM, Erickson PA, Gentry ER, et al Lipid-conjugated telomerase template antagonists sensitize resistant HER2-positive breast cancer cells to trastuzumab. Breast Cancer Res Treat. 2009; 118: 21-32.
16. Gryaznov SM, Jackson S, Dikmen G, et al Oligonucleotide conjugate GRN163L targeting human telomerase as potential anticancer and antimetastatic agent. Nucleosides Nucleotides Nucleic Acids. 2007; 26: 1577-9.
17. Hochreiter AE, Xiao H, Goldblatt EM, et al Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer. Clin Cancer Res. 2006; 12: 3184-92.
18. Herbert BS, Gellert GC, Hochreiter A, et al Lipid modification of GRN163, an N3'->P5' thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition. Oncogene. 2005; 24: 5262-8.
19. Kraemer K, Fuessel S, Schmidt U, et al Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin Cancer Res. 2003; 9: 3794-800.
20. Kondo Y, Kondo S. Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a 29, 59-oligoadenylate. Methods Mol Biol. 2007; 405: 97-112.
21. Iwado E, Daido S, Kondo Y, et al Combined effect of 2-5A-linked antisense against telomerase RNA and conventional therapies on human malignant glioma cells in vitro and in vivo. Int J Oncol. 2007; 31: 1087-95.
22. Li S, Nosrati M, Kashani-Sabet M. Knockdown of telomerase RNA using hammerhead ribozymes and RNA interference. Methods Mol Biol. 2007; 405: 113-31.
23. Tauchi T, Shin-ya K, Sashida G, et al Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia. Oncogene. 2006; 25: 5719-25.
24. Liu JP, Chen W, Schwarer AP, et al Telomerase in cancer immunotherapy. Biochim Biophys Acta. 2010; 1805: 35-42.
25. Vulliamy T, Marrone A, Goldman F, et al The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 2001; 413: 432-5.
26. Wong JM, Kyasa MJ, Hutchins L, et al Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita. Hum Genet. 2004; 115: 448-55.
27. Vulliamy TJ, Walne A, Baskaradas A, et al Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis. 2005; 34: 257-63.
28. Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 1999; 402: 551-5.
29. Walne AJ, Vulliamy T, Marrone A, et al Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet. 2007; 16: 1619-29.
30. Balci S, Engiz O, Erekul A, et al An atypical form of dyskeratosis congenita with renal agenesis and no mutation in DKC1, TERC and TERT genes. J Eur Acad Dermatol Venereol. 2008; 23: 607-8.
31. Wang C, Meier UT. Architecture and assembly of mammalian H/ACA small nucleolar and telomerase ribonucleoproteins. EMBO J. 2004; 23: 1857-67.
32. Wong JM, Collins K. Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita. Genes Dev. 2006; 20: 2848-58.
33. Armanios M, Chen JL, Chang YP, et al Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci USA. 2005; 102: 15960-4.
34. Savage SA, Giri N, Baerlocher GM, et al TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet. 2008; 82: 501-9.
35. Calado RT. Telomeres and marrow failure. Hematology Am Soc Hematol Educ Program. 2009: 338-43.
36. Mason PJ, Wilson DB, Bessler M. Dyskeratosis congenita - a disease of dysfunctional telomere maintenance. Curr Mol Med. 2005; 5: 159-70.
37. Wellinger RJ, Wolf AJ, Zakian VA. Origin activation and formation of single-strand TG1-3 tails occur sequentially in late S phase on a yeast linear plasmid. Mol Cell Biol. 1993; 13: 4057-65.
38. Wu P, van Overbeek M, Rooney S, et al Apollo contributes to G overhang maintenance and protects leading-end telomeres. Mol Cell. 2010; 39: 606-17.
39. Henderson E, Hardin CC, Walk SK, et al Telomeric DNA oligonucleotides form novel intramolecular structures containing guanine-guanine base pairs. Cell. 1987; 51: 899-908.
40. Salas TR, Petruseva I, Lavrik O, et al Human replication protein A unfolds telomeric G-quadruplexes. Nucleic Acids Res. 2006; 34: 4857-65.
41. Zaug AJ, Podell ER, Cech TR. Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension in vitro. Proc Natl Acad Sci USA. 2005; 102: 10864-9.
42. Salvati E, Leonetti C, Rizzo A, et al Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. J Clin Invest. 2007; 117: 3236-47.
43. Gomez D, Lemarteleur T, Lacroix L, et al Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing. Nucleic Acids Res. 2004; 32: 371-9.
44. Benetti R, Garcia-Cao M, Blasco MA. Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat Genet. 2007; 39: 243-50.
45. Gonzalo S, Jaco I, Fraga MF, et al DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol. 2006; 8: 416-24.
46. Sfeir A, Kosiyatrakul ST, Hockemeyer D, et al Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell. 2009; 138: 90-103.
47. Waga S, Stillman B. The DNA replication fork in eukaryotic cells. Annu Rev Biochem. 1998; 67: 721-51.
48. Diede SJ, Gottschling DE. Telomerase-mediated telomere addition in vivo requires DNA primase and DNA polymerases alpha and delta. Cell. 1999; 99: 723-33.
49. Adams Martin A, Dionne I, Wellinger RJ, et al The function of DNA polymerase alpha at telomeric G tails is important for telomere homeostasis. Mol Cell Biol. 2000; 20: 786-96.
50. Dionne I, Wellinger RJ. Processing of telomeric DNA ends requires the passage of a replication fork. Nucleic Acids Res. 1998; 26: 5365-71.
51. Adams AK, Holm C. Specific DNA replication mutations affect telomere length in Saccharomyces cerevisiae. Mol Cell Biol. 1996; 16: 4614-20.
52. Qi H, Zakian VA. The Saccharomyces telomere-binding protein Cdc13p interacts with both the catalytic subunit of DNA polymerase alpha and the telomerase-associated est1 protein. Genes Dev. 2000; 14: 1777-88.
53. Ray S, Karamysheva Z, Wang L, et al Interactions between telomerase and primase physically link the telomere and chromosome replication machinery. Mol Cell Biol. 2002; 22: 5859-68.
54. Dahlen M, Sunnerhagen P, Wang TS. Replication proteins influence the maintenance of telomere length and telomerase protein stability. Mol Cell Biol. 2003; 23: 3031-42.
55. Nakamura M, Nabetani A, Mizuno T, et al Alterations of DNA and chromatin structures at telomeres and genetic instability in mouse cells defective in DNA polymerase alpha. Mol Cell Biol. 2005; 25: 11073-88.
56. Verdun RE, Karlseder J. The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Cell. 2006; 127: 709-20.
57. Dai X, Huang C, Bhusari A, et al Molecular steps of G-overhang generation at human telomeres and its function in chromosome end protection. EMBO J. 2010; 29: 2788-801.
58. Wold MS. Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism. Annu Rev Biochem. 1997; 66: 61-92.
59. Zou Y, Liu Y, Wu X, et al Functions of human replication protein A (RPA): from DNA replication to DNA damage and stress responses. J Cell Physiol. 2006; 208: 267-73.
60. Flynn RL, Zou L. Oligonucleotide/oligosaccharide-binding fold proteins: a growing family of genome guardians. Crit Rev Biochem Mol Biol. 2010; 45: 266-75.
61. Iftode C, Daniely Y, Borowiec JA. Replication protein A (RPA): the eukaryotic SSB. Crit Rev Biochem Mol Biol. 1999; 34: 141-80.
62. Wold MS, Kelly T. Purification and characterization of replication protein A, a cellular protein required for in vitro replication of simian virus 40 DNA. Proc Natl Acad Sci USA. 1988; 85: 2523-7.
63. Zou L, Elledge SJ. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science. 2003; 300: 1542-8.
64. Smith J, Zou H, Rothstein R. Characterization of genetic interactions with RFA1: the role of RPA in DNA replication and telomere maintenance. Biochimie. 2000; 82: 71-8.
65. Ono Y, Tomita K, Matsuura A, et al A novel allele of fission yeast rad11 that causes defects in DNA repair and telomere length regulation. Nucleic Acids Res. 2003; 31: 7141-9.
66. Schramke V, Luciano P, Brevet V, et al RPA regulates telomerase action by providing Est1p access to chromosome ends. Nat Genet. 2004; 36: 46-54.
67. Rubtsova MP, Skvortsov DA, Petruseva IO, et al Replication protein A modulates the activity of human telomerase in vitro. Biochemistry. 2009; 74: 92-6.
68. Opresko PL, Otterlei M, Graakjaer J, et al The Werner syndrome helicase and exonuclease cooperate to resolve telomeric D loops in a manner regulated by TRF1 and TRF2. Mol Cell. 2004; 14: 763-74.
69. Sowd G, Wang H, Pretto D, et al Replication protein A stimulates the Werner syndrome protein branch migration activity. J Biol Chem. 2009; 284: 34682-91.
70. Arnoult N, Saintome C, Ourliac-Garnier I, et al Human POT1 is required for efficient telomere C-rich strand replication in the absence of WRN. Genes Dev. 2009; 23: 2915-24.
71. Multani AS, Chang S. WRN at telomeres: implications for aging and cancer. J Cell Sci. 2007; 120: 713-21.
72. Singh DK, Ahn B, Bohr VA. Roles of RECQ helicases in recombination based DNA repair, genomic stability and aging. Biogerontology. 2009; 10: 235-52.
73. Cheok CF, Bachrati CZ, Chan KL, et al Roles of the Bloom's syndrome helicase in the maintenance of genome stability. Biochem Soc Trans. 2005; 33: 1456-9.
74. Sinclair DA, Mills K, Guarente L. Accelerated aging and nucleolar fragmentation in yeast sgs1 mutants. Science. 1997; 277: 1313-6.
75. Lee JY, Kozak M, Martin JD, et al Evidence that a RecQ helicase slows senescence by resolving recombining telomeres. PLoS Biol. 2007; 5: 1334-44.
76. Lu CY, Tsai CH, Brill SJ, et al Sumoylation of the BLM ortholog, Sgs1, promotes telomere-telomere recombination in budding yeast. Nucleic Acids Res. 2010; 38: 488-98.
77. Bai Y, Murnane JP. Telomere instability in a human tumor cell line expressing a dominant-negative WRN protein. Hum Genet. 2003; 113: 337-47.
78. Crabbe L, Verdun RE, Haggblom CI, et al Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science. 2004; 306: 1951-3.
79. Chang S, Multani AS, Cabrera NG, et al Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat Genet. 2004; 36: 877-82.
80. Du X, Shen J, Kugan N, et al Telomere shortening exposes functions for the mouse Werner and Bloom syndrome genes. Mol Cell Biol. 2004; 24: 8437-46.
81. Opresko PL, Mason PA, Podell ER, et al POT1 stimulates RecQ helicases WRN and BLM to unwind telomeric DNA substrates. J Biol Chem. 2005; 280: 32069-80.
82. Li JL, Harrison RJ, Reszka AP, et al Inhibition of the Bloom's and Werner's syndrome helicases by G-quadruplex interacting ligands. Biochemistry. 2001; 40: 15194-202.
83. Opresko PL, von Kobbe C, Laine JP, et al Telomere-binding protein TRF2 binds to and stimulates the Werner and Bloom syndrome helicases. J Biol Chem. 2002; 277: 41110-9.
84. Machwe A, Xiao L, Orren DK. TRF2 recruits the Werner syndrome (WRN) exonuclease for processing of telomeric DNA. Oncogene. 2004; 23: 149-56.
85. Schroeder TM, German J. Bloom's syndrome and Fanconi's anemia: demonstration of two distinctive patterns of chromosome disruption and rearrangement. Humangenetik. 1974; 25: 299-306.
86. German J, Bloom D, Passarge E, et al Bloom's syndrome. VI. The disorder in Israel and an estimation of the gene frequency in the Ashkenazim. Am J Hum Genet. 1977; 29: 553-62.
87. German J, Bloom D, Passarge E. Bloom's syndrome. V. Surveillance for cancer in affected families. Clin Genet. 1977; 12: 162-8.
88. Brosh RM Jr, Majumdar A, Desai S, et al Unwinding of a DNA triple helix by the Werner and Bloom syndrome helicases. J Biol Chem. 2001; 276: 3024-30.
89. Mohaghegh P, Karow JK, Brosh RM Jr, et al The Bloom's and Werner's syndrome proteins are DNA structure-specific helicases. Nucleic Acids Res. 2001; 29: 2843-9.
90. Lillard-Wetherell K, Machwe A, Langland GT, et al Association and regulation of the BLM helicase by the telomere proteins TRF1 and TRF2. Hum Mol Genet. 2004; 13: 1919-32.
91. Harrington JJ, Lieber MR. The characterization of a mammalian DNA structure-specific endonuclease. EMBO J. 1994; 13: 1235-46.
92. Liu Y, Kao HI, Bambara RA. Flap endonuclease 1: a central component of DNA metabolism. Annu Rev Biochem. 2004; 73: 589-615.
93. Shen B, Singh P, Liu R, et al Multiple but dissectible functions of FEN-1 nucleases in nucleic acid processing, genome stability and diseases. Bioessays. 2005; 27: 717-29.
94. Murante RS, Rust L, Bambara RA. Calf 5' to 39 exo/endonuclease must slide from a 5' end of the substrate to perform structure-specific cleavage. J Biol Chem. 1995; 270: 30377-83.
95. Lyamichev V, Brow MA, Dahlberg JE. Structure-specific endonucleolytic cleavage of nucleic acids by eubacterial DNA polymerases. Science. 1993; 260: 778-83.
96. Kao HI, Campbell JL, Bambara RA. Dna2p helicase/nuclease is a tracking protein, like FEN1, for flap cleavage during Okazaki fragment maturation. J Biol Chem. 2004; 279: 50840-9.
97. Parenteau J, Wellinger RJ. Accumulation of single-stranded DNA and destabilization of telomeric repeats in yeast mutant strains carrying a deletion of RAD27. Mol Cell Biol. 1999; 19: 4143-52.
98. Parenteau J, Wellinger RJ. Differential processing of leading- and lagging-strand ends at Saccharomyces cerevisiae telomeres revealed by the absence of Rad27p nuclease. Genetics. 2002; 162: 1583-94.
99. Muftuoglu M, Wong HK, Imam SZ, et al Telomere repeat binding factor 2 interacts with base excision repair proteins and stimulates DNA synthesis by DNA polymerase beta. Cancer Res. 2006; 66: 113-24.
100. Sampathi S, Bhusari A, Shen B, et al Human flap endonuclease I is in complex with telomerase and is required for telomerase-mediated telomere mainte nance. J Biol Chem. 2009; 284: 3682-90.
101. Saharia A, Guittat L, Crocker S, et al Flap endonuclease 1 contributes to telomere stability. Curr Biol. 2008; 18: 496-500.
102. Zheng L, Zhou M, Chai Q, et al Novel function of the flap endonuclease 1 complex in processing stalled DNA replication forks. EMBO Rep. 2005; 6: 83-9.
103. Saharia A, Teasley DC, Duxin JP, et al FEN1 ensures telomere stability by facilitating replication fork re-initiation. J Biol Chem. 2010; 285: 27057-66.
104. Sharma S, Sommers JA, Gary RK, et al The interaction site of Flap Endonuclease-1 with WRN helicase suggests a coordination of WRN and PCNA. Nucleic Acids Res. 2005; 33: 6769-81.
105. Vallur AC, Maizels N. Distinct activities of exonuclease 1 and flap endonuclease 1 at telomeric g4 DNA. PLoS ONE. 2010; 5: 1-9.
106. Choe W, Budd M, Imamura O, et al Dynamic localization of an Okazaki fragment processing protein suggests a novel role in telomere replication. Mol Cell Biol. 2002; 22: 4202-17.
107. Tomita K, Kibe T, Kang HY, et al Fission yeast Dna2 is required for generation of the telomeric single-strand overhang. Mol Cell Biol. 2004; 24: 9557-67.
108. Miller KM, Rog O, Cooper JP. Semi-conservative DNA replication through telomeres requires Taz1. Nature. 2006; 440: 824-8.
109. Ye J, Lenain C, Bauwens S, et al TRF2 and apollo cooperate with topoisomerase 2alpha to protect human telomeres from replicative damage. Cell. 2010; 142: 230-42.
110. Amiard S, Doudeau M, Pinte S, et al A topological mechanism for TRF2-enhanced strand invasion. Nat Struct Mol Biol. 2007; 14: 147-54.
111. Tatsumi Y, Ezura K, Yoshida K, et al Involvement of human ORC and TRF2 in pre-replication complex assembly at telomeres. Genes Cells. 2008; 13: 1045-59.
112. Deng Z, Dheekollu J, Broccoli D, et al The origin recognition complex localizes to telomere repeats and prevents telomere-circle formation. Curr Biol. 2007; 17: 1989-95.
113. Kurth I, Gautier J. Origin-dependent initiation of DNA replication within telomeric sequences. Nucleic Acids Res. 2010; 38: 467-76.
114. Giannone RJ, McDonald HW, Hurst GB, et al The Protein Network Surrounding the Human Telomere Repeat Binding Factors TRF1, TRF2, and POT1. PLoS ONE. 2010; 5: 1-10.
115. Kim H, Lee OH, Xin H, et al TRF2 functions as a protein hub and regulates telomere maintenance by recognizing specific peptide motifs. Nat Struct Mol Biol. 2009; 16: 372-9.
116. Lenain C, Bauwens S, Amiard S, et al The Apollo 5' exonuclease functions together with TRF2 to protect telomeres from DNA repair. Curr Biol. 2006; 16: 1303-10.
117. van Overbeek M, de Lange T. Apollo, an Artemis-related nuclease, interacts with TRF2 and protects human telomeres in S phase. Curr Biol. 2006; 16: 1295-302.
118. Yang Q, Zheng YL, Harris CC. POT1 and TRF2 cooperate to maintain telomeric integrity. Mol Cell Biol. 2005; 25: 1070-80.
119. Hockemeyer D, Daniels JP, Takai H, et al Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres. Cell. 2006; 126: 63-77.
120. Hockemeyer D, Palm W, Else T, et al Telomere protection by mammalian Pot1 requires interaction with Tpp1. Nat Struct Mol Biol. 2007; 14: 754-61.
121. Hockemeyer D, Sfeir AJ, Shay JW, et al POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end. EMBO J. 2005; 24: 2667-78.
122. Ye JZ, Hockemeyer D, Krutchinsky AN, et al POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev. 2004; 18: 1649-54.
123. Denchi EL, de Lange T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature. 2007; 448: 1068-71.
124. Wu L, Multani AS, He H, et al Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell. 2006; 126: 49-62.
125. Wellinger RJ, Wolf AJ, Zakian VA. Saccharomyces telomeres acquire single-strand TG1-3 tails late in S phase. Cell. 1993; 72: 51-60.
126. Nugent CI, Hughes TR, Lue NF, et al Cdc13p: a single-strand telomeric DNA-binding protein with a dual role in yeast telomere maintenance. Science. 1996; 274: 249-52.
127. Zhao Y, Sfeir AJ, Zou Y, et al Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells. Cell. 2009; 138: 463-75.
128. Surovtseva YV, Churikov D, Boltz KA, et al Conserved Telomere Maintenance Component 1 Interacts with STN1 and Maintains Chromosome Ends in Higher Eukaryotes. Mol Cell. 2009; 36: 207-18.
129. Miyake Y, Nakamura M, Nabetani A, et al RPA-like mammalian Ctc1-Stn1-Ten1 complex binds to single-stranded DNA and protects telomeres independently of the Pot1 pathway. Mol Cell. 2009; 36: 193-206.
130. Chandra A, Hughes TR, Nugent CI, et al Cdc13 both positively and negatively regulates telomere replication. Genes Dev. 2001; 15: 404-14.
131. Grandin N, Damon C, Charbonneau M. Cdc13 cooperates with the yeast Ku proteins and Stn1 to regulate telomerase recruitment. Mol Cell Biol. 2000; 20: 8397-408.
132. Grandin N, Damon C, Charbonneau M. Ten1 functions in telomere end protection and length regulation in association with Stn1 and Cdc13. EMBO J. 2001; 20: 1173-83.
133. Grandin N, Reed SI, Charbonneau M. Stn1, a new Saccharomyces cerevisiae protein, is implicated in telomere size regulation in association with Cdc13. Genes Dev. 1997; 11: 512-27.
134. Petreaca RC, Chiu HC, Eckelhoefer HA, et al Chromosome end protection plasticity revealed by Stn1p and Ten1p bypass of Cdc13p. Nat Cell Biol. 2006; 8: 748-55.
135. Petreaca RC, Chiu HC, Nugent CI. The role of Stn1p in Saccharomyces cerevisiae telomere capping can be separated from its interaction with Cdc13p. Genetics. 2007; 177: 1459-74.
136. Puglisi A, Bianchi A, Lemmens L, et al Distinct roles for yeast Stn1 in telomere capping and telomerase inhibition. EMBO J. 2008; 27: 2328-39.
137. Garvik B, Carson M, Hartwell L. Single-stranded DNA arising at telomeres in cdc13 mutants may constitute a specific signal for the RAD9 checkpoint. Mol Cell Biol. 1995; 15: 6128-38.
138. Grossi S, Puglisi A, Dmitriev PV, et al Pol12, the B subunit of DNA polymerase alpha, functions in both telomere capping and length regulation. Genes Dev. 2004; 18: 992-1006.
139. Song X, Leehy K, Warrington RT, et al STN1 protects chromosome ends in Arabidopsis thaliana. Proc Natl Acad Sci USA. 2008; 105: 19815-20.
140. Raffa GD, Raimondo D, Sorino C, et al Verrocchio, a Drosophila OB fold-containing protein, is a component of the terminin telomere-capping complex. Genes Dev. 2010; 24: 1596-601.
141. Casteel DE, Zhuang S, Zeng Y, et al A DNA polymerase-{alpha}{middle dot}primase cofactor with homology to replication protein A-32 regulates DNA replication in mammalian cells. J Biol Chem. 2009; 284: 5807-18.
142. Wan M, Qin J, Songyang Z, et al OB-fold containing protein 1 (OBFC1), a human homologue of yeast Stn1, associates with TPP1 and is implicated in telomere length regulation. J Biol Chem. 2009; 284: 26725-31.
143. Levy D, Neuhausen SL, Hunt SC, et al Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biology. Proc Natl Acad Sci USA. 2010; 107: 9293-8.